Dataset: Exploration: The gut microbial metabolite 3-indolepropionic acid as a functional neuroprotective agent against intracerebral hemorrhage: integrating epidemiological screening with in vivo validation. - PathMap Experiment #000121

Interactive Data Viewer: Read, View, and Print from Day 1 Use our fully interactive viewer to view, read, and print this research data right from Day 1: https://pathmap.org/viewer.php?id=121 Artificial General Intelligence LLC Claim Evaluated: Exploration: The gut microbial metabolite 3-indolepropionic acid as a functional neuroprotective agent against intracerebral hemorrhage: integrating epidemiological screening with in vivo validation. This dataset contains the raw JSON execution trace, verified verbatim quotes, and MeSH-aligned logic gates generated by PathMap Studio's Veridical Enforcement engine. 🔍 Novel & Overlooked Insights 3-IPA is not only protective in ICH but also shows therapeutic potential in systemic inflammatory conditions like epirubicin-induced cardiotoxicity. The neuroprotective efficacy of 3-IPA is intrinsically linked to its role as an AhR agonist, which bridges intestinal homeostasis and systemic neuroinflammation. In the context of obesity-related osteoporosis, 3-IPA has been shown to inhibit osteoclast activation via the NF-κB/NLRP3 signaling pathway. There is a clear clinical correlation between decreased peripheral levels of 3-IPA and the severity of depression-like behaviors in mouse models, suggesting systemic metabolic monitoring is feasible. Metabolomic profiling of ICH patients reveals distinct metabolic signatures, including alterations in tryptophan pathways, which can serve as early-warning biomarkers. 3-IPA demonstrates anti-apoptotic properties in models of hepatic and renal injury caused by chemical toxins like aflatoxin B1 and chlorpyrifos. The gut-brain axis modulation by 3-IPA involves systemic metabolic pathways that influence distal organ health, including the liver and gonadal axes. 🧪 Extracted Custom Datapoints 📊 Suggested Experiments Dose-response study of 3-IPA in primate models of ICH to assess safety and blood-brain barrier permeability. Investigation of 3-IPA synergistic effects with existing standard antihypertensive care to evaluate combination therapy efficacy. 📊 Suggested Studies Longitudinal cohort study of ICH patients monitoring serum levels of tryptophan and indole metabolites to assess baseline therapeutic status. Clinical phase I/II trial evaluating the pharmacokinetics and safety of oral 3-IPA supplementation in ICH survivors. 📊 Swansons Literature Based Discovery Candidates 3-indolepropionic acid (3-IPA) supplementation may improve the prognosis of patients with Lewy body disease (LBD) by modulating the gut-brain axis and reducing neuroinflammation. 3-IPA is identified as a neuroprotective gut-microbiota derived metabolite (ID: 42360541, 41825730). LBD is characterized by gut dysbiosis, microglial activation, and neuroinflammation (ID: 42529077, 42570991). AhR pathway regulation and NF-κB signaling (ID: 41825730, 40571216). 3-IPA has been demonstrated to reduce neuroinflammation through AhR and NF-κB pathways, which are also identified as key pathways in the progression of LBD and neuroinflammation associated with alpha-synuclein pathology. 📊 Contradictions Between Evidences None found within the provided context; all studies generally align on the anti-inflammatory and neuroprotective role of 3-IPA. 📊 Repurposed Solutions 3-IPA, traditionally a gut metabolite, could be repurposed as a therapeutic intervention for various neuroinflammatory disorders, including ICH and neurodegenerative diseases like LBD, based on its potent anti-inflammatory properties via the AhR axis. Tags Attractor Table Extracted Keywords & Entities Dietary Tryptophan, _gates_from_dietary_tryptophan, Gut Microbiota, _gates_to_gut_microbiota, _gates_from_gut_microbiota, 3-indolepropionic acid (3-IPA), _gates_to_3-indolepropionic_acid_(3-ipa), _gates_from_3-indolepropionic_acid_(3-ipa), Neuroprotection in ICH, _gates_to_neuroprotection_in_ich Run Your Own Analysis PathMap is a patent-pending universal AI workbench designed to eliminate LLM hallucinations in medical research. Generate your own autonomous discovery reports at PathMap.org.